Overcome the challenges associated with biotherapeutics development using Mass Spectrometry

28th May 2020

Mass spectrometry is a valuable tool for the development of biotherapeutics. This technique can be used in a GxP environment at every step of process development and for product optimisation.

Advances in state-of-the-art method development

In the next months, our dedicated R&D teams will be exploring the development of robust and validated methods for:

  • Multiple-Attribute Monitoring

  • Identification and quantification of residual host cell proteins

  • Higher order structure analysis by crosslinking MS

  • In-process analysis of antibodies and ADCs using 2D-LC/MS

Partner with the right analytical CRO

You are looking for an analytical partner with extensive experience in the analytical development of NBEs? Our comprehensive GxP compliant analysis workflow will allow you to go further with the development of your products. Click here to learn more and contact us for more information